Brief: Ocumension Therapeutics Posts HY Adjusted Net Loss RMB125.9 Million
24/08/2023 15:59
Aug 24 (Reuters) - Ocumension Therapeutics 1477.HK :
* HY ADJUSTED NET LOSS RMB125.9 MILLION
* HY TOTAL REVENUE RMB103.7 MILLION VERSUS RMB54.5 MILLION
Source text for Eikon: ID:nHKS9Frmr8
Further company coverage: 1477.HK
((reuters.briefs@thomsonreuters.com;))
Recent news on Ocumension Therapeutics
See all newsBrief: Ocumension Therapeutics Says NMPA Accepts NDA For OT-301 (NCX 470, Bimatoprost Grenod)
Brief: Ocumension Therapeutics Says Dexamethasone Intraocular Suspension Application Accepted By NMPA
Brief: Ocumension Therapeutics Says HY Adjusted Net Loss Rmb57.5 Million
China's Ocumension Therapeutics H1 revenue surges on higher ophthalmic product sales
Ocumension jumps most in three months on China nod for new drug application